23 May 2013
Keywords: NovAliX, Graffinity, Drug discovery services, M&A
Article | 16 November 2010
Strasbourg, France-based NovAliX said this morning that it has entered into a definitive agreement to acquire a majority interest in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 November 2010
17 November 2010
© 2013 thepharmaletter.com